Gilead Sciences (NASDAQ:GILD) has reportedly settled a patent lawsuit with the federal government over its HIV drugs Truvada ...

By Taylor Sisk for KFF Health News. Broadcast version by Nadia Ramlagan for West Virginia News Service reporting for the KFF ...

"The CDC must be investigated for its misuse of PEPFAR funds," said Sen. Jim Risch (R-Idaho), following a report that funds ...

Gilead Sciences and the U.S. government have settled a billion-dollar patent dispute over Gilead's HIV prevention drugs ...

After years of sparring, the Biden administration and Gilead Sciences have settled a contentious lawsuit over patents for a ...

Many vaccines work by introducing a protein to the body that resembles part of a virus. Ideally, the immune system will ...

A major U.S. HIV/AIDS relief program is facing potential blowback amid reports that the program was used to fund abortions in southeast Africa.

Gilead Sciences reached a settlement with the Justice Department and HHS that resolves a five-year legal dispute regarding patents for its HIV prevention drugs, Truvada and Descovy.

Jose Abrigo, Esq., HIV Project Director of the Lambda Legal Defense and Education Fund explains the biggest HIV issues anticipated this year.